ASBP

Aspire Biopharma Holdings, Inc. Common Stock

3 hedge funds and large institutions have $90.4K invested in Aspire Biopharma Holdings, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-16
Holders Change %
-84.21%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
1
Reduced
1
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
CS
1
Clear Street
New York
$81.7K -$491K -43,530 -86%
UBS Group
2
UBS Group
Switzerland
$8.75K +$8.19K +728 +1,456%
FTCM
3
Fir Tree Capital Management
New York
-$2.35M -212,815 Closed
PC
4
Periscope Capital
Ontario, Canada
-$1.93M -175,000 Closed
AA
5
AQR Arbitrage
Connecticut
-$1.65M -150,000 Closed
Hudson Bay Capital Management
6
Hudson Bay Capital Management
Connecticut
-$1.66M -150,000 Closed
AI
7
Arena Investors
New York
-$1.66M -150,000 Closed
LP
8
LMR Partners
United Kingdom
-$1.65M -150,000 Closed
EAM
9
Exos Asset Management
New York
-$1.65M -150,000 Closed
FTCM
10
First Trust Capital Management
Illinois
-$1.41M -128,449 Closed
CAC
11
Cowen and Company
New York
-$1.3M -117,717 Closed
FPA
12
First Pacific Advisors
California
-$628K -56,966 Closed
GCL
13
Glazer Capital LLC
New York
-$439K -39,809 Closed
QL
14
Quarry LP
New York
-$400K -36,200 Closed
WCMNY
15
Westchester Capital Management (New York)
New York
-$397K -36,029 Closed
TCM
16
Tuttle Capital Management
Connecticut
-$187K -17,000 Closed
RCM
17
Robinson Capital Management
Michigan
-$114K -10,162 Closed
TI
18
Tidal Investments
Wisconsin
-$112K -10,111 Closed
BlackRock
19
BlackRock
New York
-$3.31K -300 Closed